J van Laar
Overview
Explore the profile of J van Laar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heslinga M, Teunissen C, Agca R, van der Woude D, Huizinga T, van Laar J, et al.
Scand J Rheumatol
. 2022 Mar;
52(3):243-249.
PMID: 35274588
Objective: Several biomarkers of cardiovascular function are found to be increased in rheumatoid arthritis (RA), with some suggesting a relationship with disease activity and improvement with adequate anti-rheumatic treatment. Promising...
2.
OReilly S, van Laar J
Clin Exp Immunol
. 2020 Aug;
201(3):231-232.
PMID: 32783250
No abstract available.
3.
te Raa G, Derks I, Navrkalova V, Skowronska A, Moerland P, van Laar J, et al.
Leukemia
. 2014 Nov;
29(5):1133-42.
PMID: 25371178
Mutations or deletions in TP53 or ATM are well-known determinants of poor prognosis in chronic lymphocytic leukemia (CLL), but only account for approximately 40% of chemo-resistant patients. Genome-wide sequencing has...
4.
Maas C, Tromp J, van Laar J, Thijssen R, Elias J, Malara A, et al.
Cell Death Dis
. 2013 Aug;
4:e782.
PMID: 23990022
In the lymph node (LN) environment, chronic lymphocytic leukemia (CLL) cells display increased NF-κB activity compared with peripheral blood CLL cells, which contributes to chemoresistance. Antagonists of cellular inhibitor of...
5.
Tonino S, van Laar J, van Oers M, Wang J, Eldering E, Kater A
Oncogene
. 2010 Oct;
30(6):701-13.
PMID: 20935673
In recent years considerable progress has been made in treatment strategies for chronic lymphocytic leukemia (CLL). However, the disease remains incurable because of the development of chemoresistance. Strategies to overcome...
6.
Rueda B, Broen J, Simeon C, Hesselstrand R, Diaz B, Suarez H, et al.
Hum Mol Genet
. 2009 Mar;
18(11):2071-7.
PMID: 19286670
The aim of this study was to investigate the possible role of STAT4 gene in the genetic predisposition to systemic sclerosis (SSc) susceptibility or clinical phenotype. A total of 1317...
7.
Binks M, Passweg J, Furst D, McSweeney P, Sullivan K, Besenthal C, et al.
Ann Rheum Dis
. 2001 May;
60(6):577-84.
PMID: 11350846
Background: Systemic sclerosis (SSc, scleroderma) in either its diffuse or limited skin forms has a high mortality when vital organs are affected. No treatment has been shown to influence the...
8.
Wils E, Hulst A, van Laar J
J Anal Toxicol
. 1988 Jan;
12(1):15-9.
PMID: 3352237
Improvements on a procedure for the determination of thiodiglycol in urine are presented. This procedure is based on the conversion of thiodiglycol to mustard gas with concentrated HCl followed by...